SCHEMBL19954142

SCHEMBL19954142

CCCNC(C)c1cc(F)cc(F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 5/20 0.36
PSEN2 P49810 5/20 0.36
APH1B Q8WW43 5/20 0.36
NCSTN Q92542 5/20 0.36
APH1A Q96BI3 5/20 0.36
PSENEN Q9NZ42 5/20 0.36
CYP3A4 P08684 2/20 0.36
LMNA P02545 2/20 0.36
HTR1A P08908 2/20 0.36
CHRM2 P08172 1/20 0.36
ADRA2A P08913 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
CHRM1 P11229 1/20 0.36
SMPD1 P17405 1/20 0.36
DRD1 P21728 1/20 0.36
TBXA2R P21731 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
ADRA1A P35348 1/20 0.36
OPRM1 P35372 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19954168 0.82 CYP3A4 (0.43) CYP3A4LMNAHTR1ACHRM2ADRA2A
SCHEMBL12812169 0.82 CYP3A4 (0.43) CYP3A4LMNAHTR1ACHRM2ADRA2A
SCHEMBL19954150 0.80 ALDH1A1 (0.51) CYP3A4LMNAHTR1ACHRM2ADRA2A
SCHEMBL13137650 0.80 ALDH1A1 (0.51) CYP3A4LMNAHTR1ACHRM2ADRA2A
SCHEMBL23159289 0.76 MEN1 (0.37) CYP3A4LMNAHTR1ACHRM2ADRA2A
SCHEMBL12812097 0.76 ADRB2 (0.47) CYP3A4LMNAADORA3SLC6A2SLC6A4
SCHEMBL6009882 0.73 CA2 (0.38) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL19954182 0.72 NR3C1 (0.35) SIGMAR1
SCHEMBL17790211 0.72 ALDH1A1 (0.36) CYP3A4SLC6A2SLC6A4SLC6A3KCNH2
SCHEMBL4827313 0.72 ALDH1A1 (0.36) CYP3A4SLC6A2SLC6A4SLC6A3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9914740-B2 Tricyclic pyrido-carboxamide derivatives as rock inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2018-03-13 US disclosed